Browsing by Subject "nadph"
Now showing items 1-1 of 1
-
Metabolic vulnerability in HER2-positive Breast Cancer
(2018)The human epidermal growth factor receptor 2, or HER2, is overexpressed in 20-30% breast cancer patients and is associated with aggressive disease. Therapies targeting HER2, including monoclonal antibodies (trastuzumab and ...